![]() |
Volumn 14, Issue 2, 2008, Pages 242-247
|
Some recent developments regarding arthropathy and inhibitors in haemophilia
|
Author keywords
Arthropathy; Haemophilia; Inhibitors; Prophylaxis; Surgery
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
ANTIBODY;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 8 ANTIBODY;
BLOOD CLOTTING FACTOR 8 INHIBITOR;
BLOOD CLOTTING FACTOR 9;
BLOOD CLOTTING FACTOR 9 ANTIBODY;
CORTICOSTEROID;
PARVOVIRUS VECTOR;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
RHENIUM 186;
SCLEROSING AGENT;
UNCLASSIFIED DRUG;
YTTRIUM 90;
ARTHROPATHY;
ARTIFICIAL EMBOLISM;
BLEEDING;
BOLUS INJECTION;
CLINICAL EFFECTIVENESS;
COMORBIDITY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
COST MINIMIZATION ANALYSIS;
DISEASE SEVERITY;
DRUG COST;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FALSE ANEURYSM;
GENE THERAPY;
HEALTH ECONOMICS;
HEMARTHROSIS;
HEMOPHILIA;
HEPATITIS C;
HUMAN;
LONG TERM CARE;
MONOTHERAPY;
NONHUMAN;
PATHOPHYSIOLOGY;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROPHYLAXIS;
QUALITY OF LIFE;
REVIEW;
SYNOVIORTHESIS;
THROMBOSIS;
TOTAL KNEE REPLACEMENT;
ADOLESCENT;
AUTOANTIBODIES;
BLOOD COAGULATION FACTORS;
CHILD;
FACTOR VIIA;
FACTOR VIII;
HEMARTHROSIS;
HEMOPHILIA A;
HEMOSTATICS;
HUMANS;
QUALITY OF LIFE;
RECOMBINANT PROTEINS;
|
EID: 40449108264
PISSN: 13518216
EISSN: 13652516
Source Type: Journal
DOI: 10.1111/j.1365-2516.2007.01632.x Document Type: Review |
Times cited : (11)
|
References (18)
|